Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone (ITI-007) in acute schizophrenia
NCT02469155Phase 3Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lumateperone in schizophrenia, sponsored by Intra-Cellular Therapies. Started Jun 2015; status: completed.
02
Drugs
lumateperone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02469155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469155.